Vertaling van "number of non-commercial " (Nederlands → Frans) :

In 2008, there was a significant increase observed in the number of applications for clinical trials and amendments (changes to an existing file) and of the percentage of phase I trials. The absolute number of non-commercial (“academic”) trials remained stable.

http://www.fagg-afmps.be/nl/bi (...) (...) [HTML]

In 2008, there was a significant increase observed in the number of applications for clinical trials and amendments (changes to an existing file) and of the percentage of phase I trials. The absolute number of non-commercial (“academic”) trials remained stable.

http://www.fagg-afmps.be/nl/bi (...) (...) [HTML]

http://www.fagg-afmps.be/fr/bi (...) [HTML]

7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@EMEA.eu.int [http ...]

http://www.ema.europa.eu/docs/ (...) (...) [HTML]

7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tél (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea.eu.int [http ...]

http://www.ema.europa.eu/docs/ (...) (...) [HTML]

http://www.ema.europa.eu/docs/ (...) [HTML]

Tel (44-20) 74 18 84 00 Fax (44-20) 74 18 84 09 E-mail: mail@emea.europa.eu [http ...]

http://www.ema.europa.eu/docs/ (...) (...) [HTML]

7 Westferry Circus, Canary Wharf, Londres, E14 4HB, Royaume-Uni Tél (44-20) 74 18 84 00 Fax (44-20) 74 18 84 09 E-mail: mail@emea.eu.int [http ...]

http://www.ema.europa.eu/docs/ (...) (...) [HTML]

http://www.ema.europa.eu/docs/ (...) [HTML]

In regulatory terms, the R&D department played an active part in the elaboration of the guidelines relating to substantial amendments, (N)IMP and specific arrangements for non-commercial trials.

http://www.fagg-afmps.be/nl/bi (...) (...) [HTML]

In regulatory terms, the R&D department played an active part in the elaboration of the guidelines relating to substantial amendments, (N)IMP and specific arrangements for non-commercial trials.

http://www.fagg-afmps.be/nl/bi (...) (...) [HTML]

http://www.fagg-afmps.be/fr/bi (...) [HTML]

EPINet TM : Exposure Prevention Information Network (standardized methods for recording and tracking percutaneous injuries and blood and body fluid contacts) FDA: Food and Drug Administration EFPSU: European Federation of Public Service Unions FOD (SPF): Federale OverheidsDienst FBZ: Fonds voor de BeroepZiekten FTC: Emtricitabine GERES: Groupe d ‘Etudes sur le Risque d’Exposition des Soignants (Frankrijk) HAART: Highly active anti retroviral therapy HBV: Hepatitis B virus HBIg: Hepatitis B-immunoglobulin HBe Ag: Hepatitis B-virus core-antigeen HBs Asn: Antistoffen tegen het oppervlakteantigeen van het hepatitis B-virus HCV: Hepatitis C virus HGR: Hoge Gezondheidsraad HGV: Hepatitis G virus HIV: Human immunodeficiency virus HOSPEEM: European ...[+++]

http://www.health.belgium.be/i (...) (...) [HTML]

CDC: Centers for Diseases Control and Prevention (USA) CJD: Creutzfeldt–Jakob disease Cp: Comprimé CSS: Conseil Supérieur de la Santé EACS: European Aids Clinical Society EPI: Equipements de protection individuelle. EPINet TM : Exposure Prevention Information Network (standardized methods for recording and tracking percutaneous injuries and blood and body fluid contacts) FDA: Food and Drug Administration EFPSU: European Federation of Public Service Unions ETP: Equivalent temps-plein FMP: Fonds des Maladies Professionnelles FTC: Emtricitabine GERES: Groupe d ‘Etudes sur le Risque d’Exposition des Soignants (France) HAART: Highly active anti retroviral therapy HOSPEEM: European Hospital and Healthcare Employers’ Association IgHB: Immunoglobul ...[+++]

http://www.health.belgium.be/i (...) (...) [HTML]

http://www.health.belgium.be/i (...) [HTML]

Non-controlling interests 44 14 30 214 Average number of shares outstanding – Basic (million) 2 288.1 2 268.2 19.9 1

http://www.novartis.be/downloa (...) (...) [HTML]

Intérêts minoritaires 44 14 30 214 Nombre moyen pondéré d’actions en circulation (en millions) 2 288,1 2 268,2 19,9 1

http://www.novartis.be/downloa (...) (...) [HTML]

http://www.novartis.be/downloa (...) [HTML]

Non-controlling interests 15 13 2 15 Average number of shares outstanding – Basic (million) 2 279.1 2 265.9 13.2 1

http://www.novartis.be/downloa (...) (...) [HTML]

Intérêts minoritaires 15 13 2 15 Nombre moyen d’actions en circulation utilisé pour le calcul du résultat de base par action (en millions) 2 279,1 2 265,9 13,2 1

http://www.novartis.be/downloa (...) (...) [HTML]

http://www.novartis.be/downloa (...) [HTML]

Non-controlling interests 35 22 13 59 Average number of shares outstanding – Basic (million) 2 282.8 2 264.9 17.9 1

http://www.novartis.be/downloa (...) (...) [HTML]

Intérêts minoritaires 35 22 13 59 Nombre moyen pondéré d’actions en circulation (en millions) 2 282,8 2 264,9 17,9 1

http://www.novartis.be/downloa (...) (...) [HTML]

http://www.novartis.be/downloa (...) [HTML]

Non-controlling interests 20 9 11 122 Average number of shares outstanding – Basic (million) 2 287.7 2 263.3 24.4 1

http://www.novartis.be/downloa (...) (...) [HTML]

Intérêts minoritaires 20 9 11 122 Nombre moyen pondéré d’actions en circulation (en millions) 2 287,7 2 263,3 24,4 1

http://www.novartis.be/downloa (...) (...) [HTML]

http://www.novartis.be/downloa (...) [HTML]

Non-controlling interests 79 36 43 119 Average number of shares outstanding – Basic (million) 2 284.4 2 266.2 18.2 1

http://www.novartis.be/downloa (...) (...) [HTML]

Intérêts minoritaires 79 36 43 119 Nombre moyen pondéré d’actions en circulation (en millions) 2 284,4 2 266,2 18,2 1

http://www.novartis.be/downloa (...) (...) [HTML]

http://www.novartis.be/downloa (...) [HTML]

Anderen hebben gezocht naar : absolute number of non-commercial arrangements for non-commercial four-digit numbers average number number of non-commercial

datacenter (28): www.wordscope.be (v4.0.br)

'number of non-commercial' ->

Date index: 2022-10-15